Commonwealth Equity Services
LXEO icon

Commonwealth Equity Services’s Lexeo Therapeutics LXEO Stock Holding History

Commonwealth Equity Services’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.8K Sell
11,123
-2,497
-18% -$13.5K ﹤0.01% 4309
2026
Q1 		$78.2K Buy
13,620
+2,386
+21% +$16.9K ﹤0.01% 4160
2025
Q4 		$112K Buy
11,234
+344
+3% +$3.14K ﹤0.01% 4097
2025
Q3 		$72K Buy
10,890
+700
+7% +$3.38K ﹤0.01% 4128
2025
Q2 		$41K Buy
+10,190
New +$33.5K ﹤0.01% 4172

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Commonwealth Equity Services's LXEO Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Lexeo Therapeutics (LXEO) stake by 18% in Q2 2026, selling an estimated $13.5K and leaving 11,123 shares worth $51.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4309.

Commonwealth Equity Services first reported a position in LXEO in Q2 2025 and has held it in 5 quarters since. The position peaked at $112K in Q4 2025. 142 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Commonwealth Equity Services held 11,123 shares of Lexeo Therapeutics worth $51.8K as of Q2 2026.
  • Commonwealth Equity Services sold 2,497 Lexeo Therapeutics shares in Q2 2026, an estimated $13.5K.
  • Lexeo Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4309 holding.
  • Commonwealth Equity Services first reported a position in Lexeo Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Commonwealth Equity Services's Lexeo Therapeutics position peaked at $112K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.